| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 02/22/2006 | CN1738798A Indole derivatives as somatostatin agonists or antagonists |
| 02/22/2006 | CN1738797A Substituted aryl thioureas and related compounds; inhibitors of viral replication |
| 02/22/2006 | CN1738618A Pharmaceutical compositions and their uses |
| 02/22/2006 | CN1242995C Novel compounds, their use and preparation |
| 02/21/2006 | US7002022 treatment of neoplastic diseases that respond to inhibition of the vascular endothelial growth factor receptor tyrosine kinase activity; tumors, retinopathy, macular degeneration |
| 02/21/2006 | US7002017 Enantioselective hydrogenation of intermediates in the synthesis of tipranavir |
| 02/21/2006 | US7001916 Epothilon derivatives, method for the production and the use thereof as pharmaceuticals |
| 02/21/2006 | US7001906 Pyrrolo (2,3-B) pyridine derivatives containing Pyran ring, useful as anticancer compounds |
| 02/21/2006 | US7001904 Guanidine derivatives quinazoline and quinoline for use in the treatment of autoimmune diseases |
| 02/21/2006 | US7001899 7-member ring N-heterocycles that have a cysteine trap substitution; treating osteoarthritis |
| 02/21/2006 | US7001895 Pyridazinones; selective inhibitors of the induced isozyme PGHS-2 (Title) and cyclooxygenase 2 (COX-2); side effect reduction; analgesics; antipyretics; antiinflamation, -arthritic and -carcinogenic agents; rheumatic diseases; |
| 02/21/2006 | CA2250347C Piperazine and piperidine compounds with high affinity for dopamine-d2 and serotonin-5ht1a receptors |
| 02/16/2006 | WO2006016178A1 Enantioselective process |
| 02/16/2006 | WO2006015986A1 Mercaptoimidazoles as ccr2 receptor antagonists |
| 02/16/2006 | WO2006015860A2 Pyrazole derivatives for treating conditions mediated by activation of the adenosine a2b or a3 receptor |
| 02/16/2006 | WO2005121097A3 Pyrazole derivatives, compositions containing such compounds and methods of use |
| 02/16/2006 | WO2005118544A3 Cycloalkyl substituted pyrimidinediamine compounds and their uses |
| 02/16/2006 | WO2005110409A3 Tetrahydropyranyl cyclopentyl 1-substituted and 1,1-disubstituted tetrahydroisoquinoline modulators of chemokine receptor activity |
| 02/16/2006 | WO2005097137A3 Advanced quinazoline based protein kinase inhibitors |
| 02/16/2006 | WO2005080352A3 Quinazoline derivatives and therapeutic use thereof |
| 02/16/2006 | WO2005080317A3 Therapeutic amide derivatives |
| 02/16/2006 | WO2005055941A3 Novel m3 muscarinic acetylcholine receptor antagonists |
| 02/16/2006 | US20060036096 Process for producing quinolinecarbaldehyde |
| 02/16/2006 | US20060036092 making 4(R)-[-2,6-diamino-purin-9-yl)-[1,3]-dioxolan-2(R)-yl]-methanol ( beta -D-DAPD); esterification, cyclization, selective reduction, purification |
| 02/16/2006 | US20060035948 e.g. 6-nitro-4-[N-(4-chlorophenyl)-N-(2-methyl-2H-tetrazol-5-ylmethyl)amino]-3-hydroxy-2-methyl-2-dimethoxymethyl-3,4-dihydro-2H-1-benzopyran; protecting neuronal cells from oxidative stress induced cell death by iron or by hydrogen peroxide; antihypoxic agent, neuroprotectant |
| 02/16/2006 | US20060035945 Prevent reproduction, infection of virus; antitumor agents |
| 02/16/2006 | US20060035932 N-aryl piperidine compounds |
| 02/16/2006 | US20060035930 4-(2,4-dichloro-5-methoxyphenyl)amino-6-methoxy-7-{[5-substituted -amino)methyl]-3-furyl}-3-quinolinecarbonitriles as kinase inhibitors |
| 02/16/2006 | US20060035925 Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 02/16/2006 | US20060035916 2,4-Pyrimidinediamine compounds and their uses |
| 02/16/2006 | US20060035891 (1S, 2R)-N4-(2-Aminocarbonylcyclopent-1-yl)-5-fluoro-N2-[4-(4-methylpiperazin-1-yl)-3-methylphenyl]-2,4-pyrimidinediamine, having antiproliferative activity, used to inhibit cellular proliferation and to treat proliferate diseases such as cancers |
| 02/16/2006 | US20060035884 N-cyclic sulfonamido inhibitors of gamma secretase |
| 02/16/2006 | US20060035870 Carboxylic acid derivatives as IP antagonists |
| 02/16/2006 | US20060035865 Lipid-rich plaque regressing agents |
| 02/16/2006 | US20060035295 Method for determination of thymidine kinase 1 activity and the use thereof |
| 02/16/2006 | CA2576581A1 Substituted indole compounds, their preparation and use in medicaments |
| 02/16/2006 | CA2573066A1 Mercaptoimidazoles as ccr2 receptor antagonists |
| 02/16/2006 | CA2572752A1 Pyrazole derivatives for treating conditions mediated by activation of the adenosine a2b or a3 receptor |
| 02/15/2006 | EP1626050A1 Sulfur-containing naphthoylimide derivatives |
| 02/15/2006 | EP1626044A1 Novel piperidine derivative |
| 02/15/2006 | EP1625121A1 Pyrimidine derivatives for the treatment of abnormal cell growth |
| 02/15/2006 | EP0994871B1 Novel substituted naphthopyrans |
| 02/15/2006 | CN1735608A Substituted benzoyl derivatives as herbicides |
| 02/15/2006 | CN1735596A Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| 02/15/2006 | CN1735595A Substituted alkyl amido piperidines |
| 02/15/2006 | CN1735593A Novel CB1 receptour inverse agonists |
| 02/15/2006 | CN1735592A Hydroxyethylamine derivatives for the treatment of alzheimer's disease |
| 02/15/2006 | CN1735416A Therapeutic combination |
| 02/15/2006 | CN1733725A Process for preparing 2-iminopyrrolidine derivatives |
| 02/15/2006 | CN1733722A Bis-heterocyclic compounds with antitumour and chemosensitising activity |
| 02/15/2006 | CN1241926C Novel intermediate for preparing camptothecin derivative (CPT-11) and correlated compound and method thereof |
| 02/15/2006 | CN1241924C Method for preparing enkephalinase and angiotensin-converting enzyme inhibitor intermediate and its intermediate |
| 02/15/2006 | CN1241916C Novel acardite compound, its preparation method and medicinal composition containing said compound |
| 02/15/2006 | CN1241909C Carboxylic acid derivatives as IP antagonists |
| 02/14/2006 | US6998416 Cyclic AMP-specific phosphodiesterase inhibitors |
| 02/14/2006 | US6998414 Substituted arylamides as IP antagonists |
| 02/14/2006 | US6998412 Heterocyclic compounds |
| 02/14/2006 | US6998407 For prophylaxis and therapy of chronic or acute inflammatory or autoimmune diseases, those associated with aberrant lymphocyte or monocyte accumulation such as arthritis, asthma, atherosclerosis, diabetic nephropathy, inflammatory bowel disease |
| 02/14/2006 | US6998256 Methods of obtaining epothilone D using crystallization and /or by the culture of cells in the presence of methyl oleate |
| 02/14/2006 | US6998233 Methods for ligand discovery |
| 02/14/2006 | CA2374643C 1-trifluoromethyl-4-hydroxy-7-piperidinylaminomethylchroman derivatives as substance p antagonists |
| 02/14/2006 | CA2263167C Ether muscarinic antagonists |
| 02/14/2006 | CA2241186C Benzimidazole derivatives |
| 02/14/2006 | CA2218945C 4-aminoquinazoline derivatives |
| 02/14/2006 | CA2192645C Tri-substituted phenyl derivatives useful as pde iv inhibitors |
| 02/14/2006 | CA2192644C Tri-substituted phenyl derivatives useful as pde iv inhibitors |
| 02/14/2006 | CA2192643C Tri-substituted phenyl derivatives useful as pde iv inhibitors |
| 02/14/2006 | CA2180155C Naphthylamides as central nervous system agents |
| 02/14/2006 | CA2135926C Substituted hexahydrobenzo[a]phenanthridines |
| 02/14/2006 | CA2105666C New centrally acting substituted phenylazacycloalkanes |
| 02/09/2006 | WO2006014665A2 Arylpyrrolidine derivatives as nk-1/ssri antagonists |
| 02/09/2006 | WO2006014136A1 Piperidine derivatives as histamine h3 receptor ligands |
| 02/09/2006 | WO2006013393A2 Quinoline derivatives as neurokinin receptor antagonists |
| 02/09/2006 | WO2005095409A3 Tetrahydroquinoline derivatives and a process for preparing the same |
| 02/09/2006 | US20060030713 N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation |
| 02/09/2006 | US20060030709 PNA monomer and precursor |
| 02/09/2006 | US20060030673 Oxygen-containing heterocyclic fused naphthopyrans |
| 02/09/2006 | US20060030618 Vanilloid receptor ligands and their use in treatments |
| 02/09/2006 | US20060030605 Pharmaceutical compounds |
| 02/09/2006 | US20060030580 Contacting phenolic piperidines with opioid receptors; analgesics, anticonvulsants, antitussive agents; diarrhea, drug addiction |
| 02/09/2006 | US20060030576 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto |
| 02/09/2006 | US20060030565 Amide derivatives and nociceptin antagonists |
| 02/09/2006 | US20060030561 2-Benzyl-2-hydroxy-4-methyl-4-phenylpentanoic acid (1-oxo-1,3-dihydroisobenzofuran-5-yl)amide for example; treating type II diabetes, obesity, hypertension, arteriosclerosis, or glaucoma |
| 02/09/2006 | US20060030560 Pyrimidine compounds |
| 02/09/2006 | US20060030557 Substituted pyridines having antiangiogenic activity |
| 02/09/2006 | US20060030553 Cell adhesion inhibitors |
| 02/09/2006 | US20060030548 Methods of using ryanodine antagonists in treating neural injury |
| 02/09/2006 | US20060030543 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease |
| 02/09/2006 | DE69717294C5 Chinazolin derivate und diese enthaltende pharmazeutische zusammenstellungen Quinazoline derivatives and those containing pharmaceutical assortments |
| 02/09/2006 | CA2577882A1 Epoxidized esters of vegetable oil fatty acids as reactive diluents |
| 02/09/2006 | CA2576112A1 Piperidine derivatives as histamine h3 receptor ligands |
| 02/09/2006 | CA2575936A1 Quinoline derivatives as neurokinin receptor antagonists |
| 02/09/2006 | CA2574966A1 Isoindoline compounds and methods of their use |
| 02/09/2006 | CA2573223A1 Aromatic compound |
| 02/08/2006 | EP1622895A2 1-aryl-3-(indol-5-yl)-prop-2-en-1-ones, compositions comprising the same and use thereof |
| 02/08/2006 | EP1622893A1 New alicyclic-amine-substituted 4-carboxamido-benzimidazoles as parp-inhibitors and antioxidants |
| 02/08/2006 | EP1622886A2 Substituted amino carboxylic acids as inhibitors of protein tyrosine phosphatase-1b |
| 02/08/2006 | EP1622876A1 Cannabinoid receptor ligands and uses thereof |
| 02/08/2006 | EP1622872A1 1,2,4-substituerte 1,2,3,4-tetrahydro-and 1,2 dihydro-quinoline and 1,2,3,4-tetrahydro-quinoxaline derivatives as cetp inhibitors for the treatment of atherosclerosis and obesity |
| 02/08/2006 | EP1622871A1 Cyclic amine derivatives, processes for their preparation, and pharmaceutical compositions containing them |